USP
-
Official Full Name
Universal Stress Protein -
Overview
USP (Universal Stress Protein) contains a USP Like domain: The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. USP enhances the rate of cell survival. USP (Universal Stress Protein) also contains a AANH like domain which belongs to Adenine nucleotide alpha hydrolases superfamily including N type ATP PPases, ATP sulphurylases Universal Stress Response protein and electron transfer flavoprotein (ETF). The domain forms a apha/beta/apha fold which binds to Adenosine nucleotide. -
Synonyms
Universal stress protein Rv1996/MT2052;USP Rv2624c;USP;Universal Stress Protein
| Cat.# | Product name | Source (Host) | Species | Tag | Protein Length | Price |
|---|
Involved Pathway
USP involved in several pathways and played different roles in them. We selected most pathways USP participated on our site, such as , which may be useful for your reference. Also, other proteins which involved in the same pathway with USP were listed below. Creative BioMart supplied nearly all the proteins listed, you can search them on our site.
| Pathway Name | Pathway Related Protein |
|---|
Protein Function
USP has several biochemical functions, for example, . Some of the functions are cooperated with other proteins, some of the functions could acted by USP itself. We selected most functions USP had, and list some proteins which have the same functions with USP. You can find most of the proteins on our site.
| Function | Related Protein |
|---|
Interacting Protein
USP has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with USP here. Most of them are supplied by our site. Hope this information will be useful for your research of USP.
Resources
Related Services
Related Products
References
- Lam, K; Chan, C; et al. Preclinical pharmacokinetics, biodistribution, radiation dosimetry and acute toxicity studies required for regulatory approval of a Clinical Trial Application for a Phase I/II clinical trial of In-111-BzDTPA-pertuzumab. NUCLEAR MEDICINE AND BIOLOGY 42:78-84(2015).
- Morris, TS; Szajek, AY; et al. USP chapter analytical procedures for recombinant therapeutic monoclonal antibodies. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 248:-(2014).
